nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer
|
Mihály, Zsuzsanna |
|
2013 |
140 |
2 |
p. 219-232 |
artikel |
2 |
A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer
|
Mayer, Erica L. |
|
2013 |
140 |
2 |
p. 331-339 |
artikel |
3 |
Comparison of efficacy of 95-gene and 21-gene classifier (Oncotype DX) for prediction of recurrence in ER-positive and node-negative breast cancer patients
|
Naoi, Yasuto |
|
2013 |
140 |
2 |
p. 299-306 |
artikel |
4 |
CYP2D6 genotype in relation to tamoxifen efficacy in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial
|
Dezentjé, V. O. |
|
2013 |
140 |
2 |
p. 363-373 |
artikel |
5 |
Dynamic changes in high and low mammographic density human breast tissues maintained in murine tissue engineering chambers during various murine peripartum states and over time
|
Chew, G. L. |
|
2013 |
140 |
2 |
p. 285-297 |
artikel |
6 |
Early predictors of not returning to work in low-income breast cancer survivors: a 5-year longitudinal study
|
Blinder, Victoria |
|
2013 |
140 |
2 |
p. 407-416 |
artikel |
7 |
Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized Phase II study comparing the incidence of peripheral neuropathy
|
Vahdat, Linda T. |
|
2013 |
140 |
2 |
p. 341-351 |
artikel |
8 |
Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice
|
Wang, Lu |
|
2013 |
140 |
2 |
p. 273-284 |
artikel |
9 |
Five or more years of adjuvant endocrine therapy in breast cancer: a meta-analysis of published randomised trials
|
Petrelli, Fausto |
|
2013 |
140 |
2 |
p. 233-240 |
artikel |
10 |
Genetic determinants of aromatase inhibitor-related arthralgia: the B-ABLE cohort study
|
Garcia-Giralt, Natalia |
|
2013 |
140 |
2 |
p. 385-395 |
artikel |
11 |
Immunohistochemical BAG1 expression improves the estimation of residual risk by IHC4 in postmenopausal patients treated with anastrazole or tamoxifen: a TransATAC study
|
Afentakis, Maria |
|
2013 |
140 |
2 |
p. 253-262 |
artikel |
12 |
Increased expression of Mitotic Arrest Deficient-Like 1 (MAD1L1) is associated with poor prognosis and insensitive to Taxol treatment in breast cancer
|
Sun, Qian |
|
2013 |
140 |
2 |
p. 323-330 |
artikel |
13 |
Lack of circadian variation and reduction of heart rate variability in women with breast cancer undergoing lumpectomy: a descriptive study
|
Hansen, Melissa V. |
|
2013 |
140 |
2 |
p. 317-322 |
artikel |
14 |
Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy
|
Russo, Andrea L. |
|
2013 |
140 |
2 |
p. 353-361 |
artikel |
15 |
Molecular imaging with a fluorescent antibody targeting carbonic anhydrase IX can successfully detect hypoxic ductal carcinoma in situ of the breast
|
Brussel, Aram S. A. van |
|
2013 |
140 |
2 |
p. 263-272 |
artikel |
16 |
Rates and predictors of consideration for adjuvant radiotherapy among high-risk breast cancer patients: a cohort study
|
Krotneva, Stanimira |
|
2013 |
140 |
2 |
p. 397-405 |
artikel |
17 |
ROLL versus RSL: toss of a coin?
|
Ahmed, M. |
|
2013 |
140 |
2 |
p. 213-217 |
artikel |
18 |
Systematic review of radioguided versus wire-guided localization in the treatment of non-palpable breast cancers
|
Ahmed, Muneer |
|
2013 |
140 |
2 |
p. 241-252 |
artikel |
19 |
The associations between a polygenic score, reproductive and menstrual risk factors and breast cancer risk
|
Warren Andersen, Shaneda |
|
2013 |
140 |
2 |
p. 427-434 |
artikel |
20 |
The Athena Breast Health Network: developing a rapid learning system in breast cancer prevention, screening, treatment, and care
|
Elson, Sarah L. |
|
2013 |
140 |
2 |
p. 417-425 |
artikel |
21 |
The oestrogen receptor coactivator CARM1 has an oncogenic effect and is associated with poor prognosis in breast cancer
|
Habashy, Hany Onsy |
|
2013 |
140 |
2 |
p. 307-316 |
artikel |
22 |
Tumour diploidy and survival in breast cancer patients with BRCA2 mutations
|
Tryggvadottir, Laufey |
|
2013 |
140 |
2 |
p. 375-384 |
artikel |